RecruitingNCT00055172
Genetic Basis of Immunodeficiency
Studying T-B+ severe combined immunodeficiency due to gamma chain deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Principal Investigator
- Warren J Leonard, M.D.National Heart, Lung, and Blood Institute (NHLBI)
- Enrollment
- 100 enrolled
- Eligibility
- 99 years · All sexes
- Timeline
- 2004
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00055172 on ClinicalTrials.govOther trials for T-B+ severe combined immunodeficiency due to gamma chain deficiency
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03597594Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)St. Jude Children's Research Hospital
- RECRUITINGPHASE1, PHASE2NCT03538899Autologous Gene Therapy for Artemis-Deficient SCIDUniversity of California, San Francisco
- RECRUITINGPHASE1NCT03311503Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan ConditioningDavid Williams
See all trials for T-B+ severe combined immunodeficiency due to gamma chain deficiency →